Cathie Wood's ARK ETFs have made a series of significant trades on Friday, February 14, 2025, continuing their dynamic investment strategy in the tech and biotech sectors. The most notable move was ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

XoZymes replaces traditional chemical production methods with an approach that integrates widely available feedstocks like sugar and biomass with advanced enzymes engineered to thrive outside living ...

Rebranding Invizyne Technologies, Inc to eXoZymes Inc.Changing NASDAQ ticker from IZTC to EXOZIntroducing but not trademarking “exozymes” as a ...

Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.

Synthetic cells that look just like natural cells but are chemically reversed could outcompete other living organisms − with ...

With a $1 million grant, the University of Iowa’s Center for Biocatalysis and Bioprocessing looks toward expanding the ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

Synthetic biologists from Yale were able to re-write the genetic code of an organism—a novel genomically recoded organism ...

His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...

Stay informed and make data-driven decisions with our Ratings Table. Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the ...